Literature DB >> 30865517

Acute increases in O-GlcNAc indirectly impair mitochondrial bioenergetics through dysregulation of LonP1-mediated mitochondrial protein complex turnover.

JaLessa N Wright1, Gloria A Benavides1, Michelle S Johnson1, Willayat Wani1, Xiaosen Ouyang1, Luyun Zou1, Helen E Collins1, Jianhua Zhang1,2, Victor Darley-Usmar1, John C Chatham1.   

Abstract

The attachment of O-linked β-N-acetylglucosamine (O-GlcNAc) to the serine and threonine residues of proteins in distinct cellular compartments is increasingly recognized as an important mechanism regulating cellular function. Importantly, the O-GlcNAc modification of mitochondrial proteins has been identified as a potential mechanism to modulate metabolism under stress with both potentially beneficial and detrimental effects. This suggests that temporal and dose-dependent changes in O-GlcNAcylation may have different effects on mitochondrial function. In the current study, we found that acutely augmenting O-GlcNAc levels by inhibiting O-GlcNAcase with Thiamet-G for up to 6 h resulted in a time-dependent decrease in cellular bioenergetics and decreased mitochondrial complex I, II, and IV activities. Under these conditions, mitochondrial number was unchanged, whereas an increase in the protein levels of the subunits of several electron transport complex proteins was observed. However, the observed bioenergetic changes appeared not to be due to direct increased O-GlcNAc modification of complex subunit proteins. Increases in O-GlcNAc were also associated with an accumulation of mitochondrial ubiquitinated proteins; phosphatase and tensin homolog induced kinase 1 (PINK1) and p62 protein levels were also significantly increased. Interestingly, the increase in O-GlcNAc levels was associated with a decrease in the protein levels of the mitochondrial Lon protease homolog 1 (LonP1), which is known to target complex IV subunits and PINK1, in addition to other mitochondrial proteins. These data suggest that impaired bioenergetics associated with short-term increases in O-GlcNAc levels could be due to impaired, LonP1-dependent, mitochondrial complex protein turnover.

Entities:  

Keywords:  LonP1; Thiamet-G; bioenergetics; mitochondria; protein -GlcNAcylation; protein turnover

Mesh:

Substances:

Year:  2019        PMID: 30865517      PMCID: PMC6620580          DOI: 10.1152/ajpcell.00491.2018

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  63 in total

1.  Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing.

Authors:  J M Cooper; V M Mann; A H Schapira
Journal:  J Neurol Sci       Date:  1992-11       Impact factor: 3.181

2.  Mitochondrial LON protease-dependent degradation of cytochrome c oxidase subunits under hypoxia and myocardial ischemia.

Authors:  Naresh B V Sepuri; Rajesh Angireddy; Satish Srinivasan; Manti Guha; Joseph Spear; Bin Lu; Hindupur K Anandatheerthavarada; Carolyn K Suzuki; Narayan G Avadhani
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-04-23       Impact factor: 3.991

3.  High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.

Authors:  Sujith Dassanayaka; Ryan D Readnower; Joshua K Salabei; Bethany W Long; Allison L Aird; Yu-Ting Zheng; Senthilkumar Muthusamy; Heberty T Facundo; Bradford G Hill; Steven P Jones
Journal:  Biochem J       Date:  2015-04-01       Impact factor: 3.857

4.  Augmented O-GlcNAc signaling via glucosamine attenuates oxidative stress and apoptosis following contrast-induced acute kidney injury in rats.

Authors:  Jiachang Hu; Rongyi Chen; Ping Jia; Yi Fang; Tongqiang Liu; Nana Song; Xialian Xu; Jun Ji; Xiaoqiang Ding
Journal:  Free Radic Biol Med       Date:  2016-12-23       Impact factor: 7.376

5.  Cardioprotection by N-acetylglucosamine linkage to cellular proteins.

Authors:  Steven P Jones; Natasha E Zachara; Gladys A Ngoh; Bradford G Hill; Yasushi Teshima; Aruni Bhatnagar; Gerald W Hart; Eduardo Marbán
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

6.  Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition.

Authors:  Gladys A Ngoh; Lewis J Watson; Heberty T Facundo; Wolfgang Dillmann; Steven P Jones
Journal:  J Mol Cell Cardiol       Date:  2008-05-02       Impact factor: 5.000

7.  Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2.

Authors:  Voraratt Champattanachai; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Cell Physiol       Date:  2008-03-26       Impact factor: 4.249

8.  Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal.

Authors:  Bradford G Hill; Brian P Dranka; Luyun Zou; John C Chatham; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

9.  O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.

Authors:  Zhen Zhang; Ee Phie Tan; Nicole J VandenHull; Kenneth R Peterson; Chad Slawson
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-01       Impact factor: 5.555

10.  Methods for assessing mitochondrial quality control mechanisms and cellular consequences in cell culture.

Authors:  Matthew Redmann; Gloria A Benavides; Willayat Yousuf Wani; Taylor F Berryhill; Xiaosen Ouyang; Michelle S Johnson; Saranya Ravi; Kasturi Mitra; Stephen Barnes; Victor M Darley-Usmar; Jianhua Zhang
Journal:  Redox Biol       Date:  2018-04-10       Impact factor: 11.799

View more
  6 in total

Review 1.  Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells.

Authors:  Nicholas Esch; Seokwon Jo; Mackenzie Moore; Emilyn U Alejandro
Journal:  J Diabetes Res       Date:  2020-12-16       Impact factor: 4.011

2.  Blocked O-GlcNAc cycling alters mitochondrial morphology, function, and mass.

Authors:  Elizabeth O Akinbiyi; Lara K Abramowitz; Brianna L Bauer; Maria S K Stoll; Charles L Hoppel; Chao-Pin Hsiao; John A Hanover; Jason A Mears
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

Review 3.  Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.

Authors:  Steven N Austad; Scott Ballinger; Thomas W Buford; Christy S Carter; Daniel L Smith; Victor Darley-Usmar; Jianhua Zhang
Journal:  Acta Pharm Sin B       Date:  2021-06-30       Impact factor: 11.413

4.  The intra-mitochondrial O-GlcNAcylation system rapidly modulates OXPHOS function and ROS release in the heart.

Authors:  Justine Dontaine; Asma Bouali; Frederic Daussin; Laurent Bultot; Didier Vertommen; Manon Martin; Raahulan Rathagirishnan; Alexanne Cuillerier; Sandrine Horman; Christophe Beauloye; Laurent Gatto; Benjamin Lauzier; Luc Bertrand; Yan Burelle
Journal:  Commun Biol       Date:  2022-04-12

Review 5.  Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.

Authors:  John C Chatham; Martin E Young; Jianhua Zhang
Journal:  Curr Opin Pharmacol       Date:  2020-09-13       Impact factor: 4.768

6.  A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability.

Authors:  Veronica M Pravata; Mehmet Gundogdu; Sergio G Bartual; Andrew T Ferenbach; Marios Stavridis; Katrin Õunap; Sander Pajusalu; Riina Žordania; Monica H Wojcik; Daan M F van Aalten
Journal:  FEBS Lett       Date:  2019-11-07       Impact factor: 3.864

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.